Morocco is advancing its pharmaceutical industry with a goal to produce 70% of its domestic medicine needs by 2026, according to recent government statements. The country currently covers about 60% of local demand, with plans to expand production capacity and reduce imports.
The strategy includes increasing exports to African markets, leveraging Morocco's existing pharmaceutical infrastructure and free trade agreements. In 2025, Moroccan pharmaceutical exports to Africa were valued at approximately $200 million, with key markets in West and Central Africa.
Industry experts note that Morocco's pharmaceutical sector has grown steadily, supported by investments in manufacturing plants and research. The government has also introduced incentives for local production of generic drugs and vaccines, aiming to position Morocco as a regional hub.
However, challenges remain, including reliance on imported raw materials and competition from other emerging producers. The success of the plan will depend on continued investment and regulatory reforms.
